Tool-in-Lesion Confirmation

The Galaxy System™ with TiLT+ Technology™ is designed to overcome CT-to-body divergence and improve overall diagnostic yield.

 

This proprietary technology is designed to allow for real-time navigation updates and guidance in all areas of the lung, including an augmented fluoro feature designed to overlay graphics during live fluoro video to help locate non-visual lesions.

“The risk of a missed diagnosis has always been a frustrating reality of peripheral bronchoscopy. Integrated tomosynthesis has been missing from the first generation of both robotic platforms and the data demonstrates their limited inability to deal with CT to body divergence.”

— D. Kyle Hogarth, MD, FCCP

Noah_Galaxy_PG_1200x620pxl_Hogarth_1 (1)

Reduced risk of cross-contamination

With a focus on procedural efficiency, the Galaxy System™ includes a single-use bronchoscope and accessories for faster turnaround, less cleaning, and reduced risk of cross-contamination.

 

Our world class scope design has an integrated camera for always-on vision and has been designed to reach anywhere in the lung within 2 cm of the pleura.

 

“Bronchoscope reprocessing is the hidden cost and burden on the support team. The ability to toss the scope and accessories at the end of each case reduces the burden on my team and improves turnover times.”

— Krish Bhadra, MD (CHI Memorial)

Noah_Galaxy_TiLT_PG_1200x620pxl_Bhadra_2 (1)
streamlined workflow draft

Streamlined workflow

The Galaxy System™ is designed to have a smaller footprint compared to other bronchoscopic robotic systems currently on the market. Our single robotic cart is designed to fit in most bronch suites.

 

The innovative single arm design can be integrated seamlessly with any C-arm or cone beam CT system. Additionally, the cart is lighter than other systems currently on the market* to make it easier to position and move between rooms.

“Beyond the integration of tomosynthesis to improve location and diagnosis, the move to single use scopes and a much smaller footprint all lend themselves to more efficient operation and the ability for more clinics and systems to treat more patients.”

— Bobby Mahajan, MD (Inova Fairfax)

Noah_Galaxy_PG_1200x620pxl_Mahajan_3 (1)

More questions?

Get in touch